Cargando…
Animal models of Parkinson’s disease: a guide to selecting the optimal model for your research
Parkinson’s disease (PD) is a complex, multisystem disorder characterised by α-synuclein (SNCA) pathology, degeneration of nigrostriatal dopaminergic neurons, multifactorial pathogenetic mechanisms and expression of a plethora of motor and non-motor symptoms. Animal models of PD have already been in...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661507/ https://www.ncbi.nlm.nih.gov/pubmed/34956652 http://dx.doi.org/10.1042/NS20210026 |
_version_ | 1784613376409731072 |
---|---|
author | Lama, Joana Buhidma, Yazead Fletcher, Edward J.R. Duty, Susan |
author_facet | Lama, Joana Buhidma, Yazead Fletcher, Edward J.R. Duty, Susan |
author_sort | Lama, Joana |
collection | PubMed |
description | Parkinson’s disease (PD) is a complex, multisystem disorder characterised by α-synuclein (SNCA) pathology, degeneration of nigrostriatal dopaminergic neurons, multifactorial pathogenetic mechanisms and expression of a plethora of motor and non-motor symptoms. Animal models of PD have already been instructive in helping us unravel some of these aspects. However, much remains to be discovered, requiring continued interrogation by the research community. In contrast with the situation for many neurological disorders, PD benefits from of a wide range of available animal models (pharmacological, toxin, genetic and α-synuclein) but this makes selection of the optimal one for a given study difficult. This is especially so when a study demands a model that displays a specific combination of features. While many excellent reviews of animal models already exist, this review takes a different approach with the intention of more readily informing this decision-making process. We have considered each feature of PD in turn – aetiology, pathology, pathogenesis, motor dysfunctions and non-motor symptoms (NMS) – highlighting those animal models that replicate each. By compiling easily accessible tables and a summary figure, we aim to provide the reader with a simple, go-to resource for selecting the optimal animal model of PD to suit their research needs. |
format | Online Article Text |
id | pubmed-8661507 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Portland Press Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86615072021-12-23 Animal models of Parkinson’s disease: a guide to selecting the optimal model for your research Lama, Joana Buhidma, Yazead Fletcher, Edward J.R. Duty, Susan Neuronal Signal Cell Death & Injury Parkinson’s disease (PD) is a complex, multisystem disorder characterised by α-synuclein (SNCA) pathology, degeneration of nigrostriatal dopaminergic neurons, multifactorial pathogenetic mechanisms and expression of a plethora of motor and non-motor symptoms. Animal models of PD have already been instructive in helping us unravel some of these aspects. However, much remains to be discovered, requiring continued interrogation by the research community. In contrast with the situation for many neurological disorders, PD benefits from of a wide range of available animal models (pharmacological, toxin, genetic and α-synuclein) but this makes selection of the optimal one for a given study difficult. This is especially so when a study demands a model that displays a specific combination of features. While many excellent reviews of animal models already exist, this review takes a different approach with the intention of more readily informing this decision-making process. We have considered each feature of PD in turn – aetiology, pathology, pathogenesis, motor dysfunctions and non-motor symptoms (NMS) – highlighting those animal models that replicate each. By compiling easily accessible tables and a summary figure, we aim to provide the reader with a simple, go-to resource for selecting the optimal animal model of PD to suit their research needs. Portland Press Ltd. 2021-12-08 /pmc/articles/PMC8661507/ /pubmed/34956652 http://dx.doi.org/10.1042/NS20210026 Text en © 2021 The Author(s). https://creativecommons.org/licenses/by/4.0/This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY) (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Cell Death & Injury Lama, Joana Buhidma, Yazead Fletcher, Edward J.R. Duty, Susan Animal models of Parkinson’s disease: a guide to selecting the optimal model for your research |
title | Animal models of Parkinson’s disease: a guide to selecting the optimal model for your research |
title_full | Animal models of Parkinson’s disease: a guide to selecting the optimal model for your research |
title_fullStr | Animal models of Parkinson’s disease: a guide to selecting the optimal model for your research |
title_full_unstemmed | Animal models of Parkinson’s disease: a guide to selecting the optimal model for your research |
title_short | Animal models of Parkinson’s disease: a guide to selecting the optimal model for your research |
title_sort | animal models of parkinson’s disease: a guide to selecting the optimal model for your research |
topic | Cell Death & Injury |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661507/ https://www.ncbi.nlm.nih.gov/pubmed/34956652 http://dx.doi.org/10.1042/NS20210026 |
work_keys_str_mv | AT lamajoana animalmodelsofparkinsonsdiseaseaguidetoselectingtheoptimalmodelforyourresearch AT buhidmayazead animalmodelsofparkinsonsdiseaseaguidetoselectingtheoptimalmodelforyourresearch AT fletcheredwardjr animalmodelsofparkinsonsdiseaseaguidetoselectingtheoptimalmodelforyourresearch AT dutysusan animalmodelsofparkinsonsdiseaseaguidetoselectingtheoptimalmodelforyourresearch |